Thus, concerted simultaneous inhibition of XIAP-CCS complex formation, and activation of MURR1 in ALS patients by the peptides is a promising effective therapeutic strategy that need urgent research attention. The gene discussed is CCS; the disease is amyotrophic lateral sclerosis.